Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.020
-0.050 (-4.67%)
At close: Nov 7, 2025, 4:00 PM EST
1.000
-0.020 (-1.96%)
After-hours: Nov 7, 2025, 5:07 PM EST
Gelteq Revenue
Gelteq had revenue of 155.71K AUD in the quarter ending December 31, 2024, with 305.06% growth. This brings the company's revenue in the last twelve months to 377.85K, up 10.19% year-over-year. In the fiscal year ending June 30, 2024, Gelteq had annual revenue of 143.31K, down -58.21%.
Revenue (ttm)
377.85K AUD
Revenue Growth
+10.19%
P/S Ratio
36.51
Revenue / Employee
47,231 AUD
Employees
8
Market Cap
9.84M USD
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 143.31K | -199.59K | -58.21% |
| Jun 30, 2023 | 342.90K | -29.17K | -7.84% |
| Jun 30, 2022 | 372.07K | 212.20K | 132.73% |
| Jun 30, 2021 | 159.87K | - | - |
| Jun 30, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GELS News
- 2 months ago - Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - GlobeNewsWire
- 2 months ago - Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market - GlobeNewsWire
- 2 months ago - Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs - Accesswire
- 3 months ago - Healthy Extracts Reports Record Q2 2025 Net Revenue, Driving Positive EPS and EBITDA; Increases 2025 Net Revenue Guidance by 50% - Accesswire
- 3 months ago - Healthy Extracts Expects Record Sales for Q2 2025, Driving Strong Positive Adj. EBITDA - Accesswire
- 4 months ago - Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - GlobeNewsWire
- 5 months ago - Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner - GlobeNewsWire
- 9 months ago - Gelteq's Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand - GlobeNewsWire